Pharmaceutical Industry
HealthNovo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze
By Prarthana PrakashNovember 3, 2023
By Sheryl EstradaNovember 3, 2023
NewslettersCEO of Ozempic prescription startup Calibrate steps down as investors eye ‘rapid down-sizing’ of consumer business
By Jessica MathewsOctober 31, 2023
By The Associated PressOctober 30, 2023
HealthU.S. cancer patients face nationwide shortages of life-saving chemo drugs as ‘race to the bottom’ makes their production unprofitable
By Christiaan HetznerOctober 28, 2023
CommentaryClimate change is our greatest health crisis. The same investments can often address both threats
By Vanessa Kerry and Paul HudsonOctober 19, 2023
HealthWhy a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
By Angel Adegbesan and BloombergOctober 13, 2023
HealthHorseshoe crab blood is vital to modern medicine. A new lab-made alternative could save the species
By Kristoffer Whitney, Jolie Crunelle and The ConversationOctober 13, 2023
HealthCVS CEO says pharmacist burnout led to a walkout: ‘We are at the same level of demand as we were in 2021’ for COVID shots
By Erin PraterOctober 10, 2023
FinanceWall Street is now betting against restaurant stocks because of Novo Nordisk’s Ozempic and high interest rates
By Prarthana PrakashOctober 10, 2023
Health‘These pharmacists always look stressed’: Drugstores struggle with thin staffing and recruiting challenges as busiest season begins
By Tom Murphy and The Associated PressOctober 7, 2023
LifestyleWeight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says
By Chloe TaylorOctober 5, 2023
FinanceDrugs aiding weight-loss like Ozempic have so much promise, a major bank is telling investors to short junk-food credit
By Prarthana PrakashOctober 4, 2023
Most Popular
